BCLI Brainstorm Cell Therapeutics Inc.

NASDAQ
$0.88

Brainstorm Cell Therapeutics Inc. (BCLI) is expected to report earnings on February 15, 2027, after the market close.

Brainstorm Cell Therapeutics Reported Earnings
Monday, November 16, 2026 · 4:01 PM ET
Earnings Date
Feb 15
Monday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a developer of stem cell technologies to provide treatments for currently incurable neurodegenerative diseases.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.